Literature DB >> 17320661

Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.

Tsunenori Kondo1, Hayakazu Nakazawa, Fumio Ito, Yasunobu Hashimoto, Hiroshi Toma, Kazunari Tanabe.   

Abstract

OBJECTIVES: To determine the primary site and incidence of lymph node metastases in urothelial carcinoma of the upper urinary tract.
METHODS: From January 1989 to October 2005, we treated 181 patients with urothelial carcinoma of the upper urinary tract. The findings of the imaging studies when lymph node metastasis was diagnosed and the pathologic examination findings of the nodal specimens were analyzed. If multiple nodal metastases were present, the largest lymph node was considered the primary site.
RESULTS: Of the 181 patients, 42 (23.2%) had nodal involvement. Lymphatic metastasis was confirmed pathologically in 23 patients and 19 were clinically considered to have nodal metastasis without pathologic diagnosis because these patients died of the disease with deterioration of nodal involvement during follow-up. In tumors of the right renal pelvis, the primary metastatic sites were the right renal hilar, paracaval, and retrocaval nodes. Tumors of the upper two thirds of the right ureter primarily metastasized to the retrocaval and inter-aortocaval nodes. In tumors of the left renal pelvis, the primary sites were the left renal hilar and para-aortic nodes. Tumors of the upper two thirds of the left ureter primarily metastasized to the para-aortic nodes. Tumors of the lower ureter primarily metastasized inferiorly to the aortic bifurcation.
CONCLUSIONS: Lymphadenectomy for urothelial carcinoma of the right renal pelvis and upper two thirds of the ureter should include a relatively wide area, compared with regional lymph nodes conventionally addressed, encompassing the paracaval, retrocaval, and inter-aortocaval nodes.

Entities:  

Mesh:

Year:  2007        PMID: 17320661     DOI: 10.1016/j.urology.2006.10.014

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  38 in total

1.  [Diagnostic procedures in upper urinary tract urothelial carcinoma].

Authors:  O Patschan; M Horstmann; C Thomas; H P Schlemmer; A Stenzl
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

Review 2.  Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.

Authors:  Atiqullah Aziz; Jakub Dobruch; Kees Hendricksen; Luis A Kluth; Andrea Necchi; Aidan Noon; Michael Rink; Florian Roghmann; Roland Seiler; Paolo Gontero; Wassim Kassouf; Shahrokh F Shariat; Evanguelos Xylinas
Journal:  World J Urol       Date:  2017-01-10       Impact factor: 4.226

3.  Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.

Authors:  Junichi Inokuchi; Kentaro Kuroiwa; Yoshiyuki Kakehi; Mikio Sugimoto; Toshiki Tanigawa; Hiroyuki Fujimoto; Momokazu Gotoh; Naoya Masumori; Osamu Ogawa; Masatoshi Eto; Chikara Ohyama; Akito Yamaguchi; Hideyasu Matsuyama; Tomohiko Ichikawa; Tomohiko Asano; Junki Mizusawa; Junko Eba; Seiji Naito
Journal:  World J Urol       Date:  2017-05-15       Impact factor: 4.226

4.  Mining the data on UTUC management.

Authors:  Michael J Leveridge
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

Review 5.  Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

Authors:  Andrea B Apolo; Vanessa Hoffman; Matthew G Kaag; David M Latini; Cheryl T Lee; Jonathan E Rosenberg; Margaret Knowles; Dan Theodorescu; Bogdan A Czerniak; Jason A Efstathiou; Matthew L Albert; Srikala S Sridhar; Vitaly Margulis; Surena F Matin; Matthew D Galsky; Donna Hansel; Ashish M Kamat; Thomas W Flaig; Angela B Smith; Edward Messing; Diane Zipursky Quale; Yair Lotan
Journal:  Urol Oncol       Date:  2014-07-25       Impact factor: 3.498

6.  The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.

Authors:  Adil Ouzzane; Pierre Colin; Tarek P Ghoneim; Marc Zerbib; Alexandre De La Taille; François Audenet; Fabien Saint; Nicolas Hoarau; Emilie Adam; Marie Dominique Azemar; Henri Bensadoun; Luc Cormier; Olivier Cussenot; Alain Houlgatte; Gilles Karsenty; Charlotte Maurin; François Xavier Nouhaud; Véronique Phe; Thomas Polguer; Mathieu Roumiguié; Alain Ruffion; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-12-11       Impact factor: 4.226

7.  Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.

Authors:  Tsunenori Kondo; Isao Hara; Toshio Takagi; Yoshiki Kodama; Yasunobu Hashimoto; Hirohito Kobayashi; Junpei Iizuka; Kenji Omae; Kazuhiko Yoshida; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2016-07-23       Impact factor: 3.402

8.  Laparoscopic nephroureterectomy and management of the distal ureter: a review of current techniques and outcomes.

Authors:  Davis P Viprakasit; Amanda M Macejko; Robert B Nadler
Journal:  Adv Urol       Date:  2009-01-08

9.  Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter.

Authors:  Shilajit D Kundu; Scott E Eggener
Journal:  Adv Urol       Date:  2009-01-26

10.  Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.

Authors:  Kang Su Cho; Hyun Min Choi; Kyochul Koo; Sung Jin Park; Koon Ho Rha; Young Deuk Choi; Byung Ha Chung; Nam Hoon Cho; Seung Choul Yang; Sung Joon Hong
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.